News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
About
Partnerships

|Articles|August 9, 2011

Treatment Modalities for Female Genital Cancer (Radiotherapy)

Author(s)Samir Fouad Abdel Aziz, MD

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Related Content

FDA-cleared vaginal device launches, asthma control as fetal protection, IVF's bladder symptom cues

FDA-cleared vaginal device launches, asthma control as fetal protection, IVF's bladder symptom cues

ByJoshua Fitch, Senior Editor

August 21st 2026

Bladder symptoms during IVF carry systemic cues that extend beyond the urinary tract

ByAleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES

August 21st 2026

Post-egg retrieval urinary symptoms often mimic UTI without representing true infection

ByAleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES

August 14th 2026

New fertility tool to help determine chances of successful IVF launches | stock.adobe.com.

New fertility tool to help determine chances of successful IVF launches

ByJoshua Fitch, Senior Editor

July 29th 2026

Subfecundity, not IVF, linked to elevated neurodevelopmental risk in offspring | Image credit: stock.adobe.com.

Subfecundity, not IVF, linked to elevated neurodevelopmental risk in offspring

ByJoshua Fitch, Senior Editor

July 28th 2026

Latest CME

Join Us at The Pathology Meeting in Las Vegas

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

Join Us at The Pathology Meeting in Las Vegas

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 4-5, 2026

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Trending on Contemporary OB/GYN

Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal

Certolizumab pegol receives FDA BTD for adverse pregnancy outcomes in APS

Phase 3 LUNA study: atogepant reduces menstrual migraine days vs. placebo

Amber Watters, MD, on emergency preparedness and building a version program

New tool translates pregnancy test research into individualized patient counseling resource